CompletedInterventionalNot ApplicableLast updated Apr 2, 2026

Multi-modal Neuroimaging in Alzheimer's Disease IMAP+

Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging

Overview

ClinicalTrials.gov ID: NCT01638949
Lead Sponsor: University Hospital, CaenOTHER
Brief Summary: Alzheimer's disease (AD) is a major public health problem due to its socio-economic weight. An early diagnosis of AD is urgently needed as it would constitute a determinant breakthrough from a social, financial and research standpoints. Therefore, the investigators need predictive markers of AD, and neuroimaging is a particularly promising tool, especially when using complementary neuroimaging techniques and a longitudinal design, allowing to assess the relationships between the different biomarkers of the disease, their dynamic and their chronology.

Status

Overall Status: Completed
Start Date: May 2012Actual
Primary Completion Date: Jan 20, 2020Actual
Completion Date: Sep 20, 2022Actual

Study Record Dates

First Submitted: May 22, 2012
First Submitted that Met QC Criteria: Jul 10, 2012
First Posted: Jul 12, 2012Estimated
Last Update Submitted that Met QC Criteria: Mar 30, 2026
Last Update Posted: Apr 2, 2026Actual
Last Verified: Apr 2014

NCT01554202Unknown status

Multi-modal Neuroimaging in Alzheimer's Disease

NCT02839187Completed

Neuro Imaging and Multimodal Alzheimer's Disease

NCT01582919Completed

Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study

NCT00684281Completed

Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment

NCT01815112Terminated

Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging

NCT06448403Recruiting

Multimodal Assesment of Alzheimer Patients